Corrigendum to "CHST3 and CHST13 polymorphisms as predictors of bosentan-induced liver toxicity in Japanese patients with pulmonary arterial hypertension" [Pharmacol. Res. 135 (2018) 259-264].

Kennosuke Yorifuji Yuko Uemura Shinji Horibata Goh Tsuji Yoko Suzuki Kazuya Miyagawa Kazuhiko Nakayama Ken-Ichi Hirata Shunichi Kumagai Noriaki Emoto

Pharmacol Res

Laboratory of Clinical Pharmaceutical Science, Kobe Pharmaceutical University, 4-19-1 Motoyama-kitamachi, Higashinada, Kobe 658-8558, Japan; Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe Graduate School of Medicine, 7-5-1 Kusunoki, Chuo, Kobe 650-0017, Japan. Electronic address:

Published: January 2019

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.phrs.2018.09.018	DOI Listing

Publication Analysis

Top Keywords

corrigendum "chst3

"chst3 chst13

chst13 polymorphisms

polymorphisms predictors

predictors bosentan-induced

bosentan-induced liver

liver toxicity

toxicity japanese

japanese patients

patients pulmonary

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!